130
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Association of Umbilical Cord Serum Oxidative Stress Markers, ADMA and Adiponectin with Adverse Fetal Outcomes in Hypertensive Disorders of Pregnancy

, , &
Pages 227-240 | Received 18 Jul 2022, Accepted 05 Aug 2022, Published online: 19 Aug 2022

References

  • Shah S, Gupta A. Hypertensive disorders of pregnancy. Cardiol Clin. 2019;37(3):345–54. doi:10.1016/j.ccl.2019.04.008.
  • Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of hypertension in pregnancy. J Pregnancy. 2012;2012:105918. doi:10.1155/2012/105918.
  • Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol. 2013;25(2):124–32. doi:10.1097/GCO.0b013e32835e0ef5.
  • American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–31.
  • Shen M, Smith GN, Rodger M, White RR, Walker MC, Wen SW. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PloS One. 2017;12(4):e0175914. doi:10.1371/journal.pone.0175914.
  • Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and current clinical management of preeclampsia. Curr Hypertens Rep. 2017;19(8):61. doi:10.1007/s11906-017-0757-7.
  • Blencowe H., Cousens S, Chou D, Oestergaard M, Say L, Moller A-B, Kinney M, Lawn J. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health. 2013;10(S1):S2 doi:10.1186/1742-4755-10-S1-S2.
  • Goulopoulou S, Davidge ST. Molecular mechanisms of maternal vascular dysfunction in preeclampsia. Trends Mol Med. 2015;21(2):88–97. doi:10.1016/j.molmed.2014.11.009.
  • Aouache R, Biquard L, Vaiman D, et al. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018;19(5):1496–(1–29). doi:10.3390/ijms19051496.
  • Gaweł S, Wardas M, Niedworok E, et al. [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiadomosci Lek Wars Pol. 2004;57:453–5.
  • Taravati A, Tohidi F. Comprehensive analysis of oxidative stress markers and antioxidants status in preeclampsia. Taiwan J Obstet Gynecol. 2018;57(6):779–90. doi:10.1016/j.tjog.2018.10.002.
  • Veas CJ, Aguilera VC, Muñoz IJ, Gallardo VI, Miguel PL, González MA, Lamperti LI, Escudero CA, Aguayo CR. Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia. J Matern-Fetal Neonatal Med. 2011;24(11):1371–7. doi:10.3109/14767058.2011.556204.
  • Huang L-T, Hsieh C-S, Chang K-A, Tain Y-L. Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming. Int J Mol Sci. 2012;13(11):14606–22. doi:10.3390/ijms131114606.
  • Stepanian A, Cohen-Moatti M, Sanglier T, Legendre P, Ameziane N, Tsatsaris V, Mandelbrot L, de Prost D, Veyradier A. Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology. Arterioscler Thromb Vasc Biol. 2011;31(7):1703–9. doi:10.1161/ATVBAHA.111.223610.
  • Fan M, Wang X, Peng X, Feng S, Zhao J, Liao L, Zhang Y, Hou Y, Liu J. Prognostic value of plasma von Willebrand factor levels in major adverse cardiovascular events: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2020;20(1):72. doi:10.1186/s12872-020-01375-7.
  • Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf). 2012;76(1):2–11. doi:10.1111/j.1365-2265.2011.04234.x.
  • Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW, Wallace K, LaMarca B. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 2016;130(6):409–19. doi:10.1042/CS20150702.
  • WHONMHNHDEPG14.pdf [Internet]. [cited 2020 May 20]. Available from: https://apps.who.int/iris/bitstream/handle/10665/133708/WHONMHNHDEPG14.7;jsessionid=DC7ACA9EE93A0E5D1D76F7E86FEC447D?sequence=1.
  • von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hyperten Pregnancy. 2003;22(2):143–8. doi:10.1081/PRG-120021060.
  • Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239(1):70–6. doi:10.1006/abio.1996.0292.
  • Bharadwaj S, Bhat VB, Vickneswaran V, et al. Oxidative stress in preeclamptic mother – newborn dyads and its correlation with early neonatal outcome – a case control study. J Matern-Fetal Neonatal Med. 2018;31:1548–53.
  • Negi R, Pande D, Karki K, Kumar A, Khanna RS, Khanna HD. Trace elements and antioxidant enzymes associated with oxidative stress in the pre-eclamptic/eclamptic mothers during fetal circulation. Clin Nutr Edinb Scotl. 2012;31(6):946–50. doi:10.1016/j.clnu.2012.04.005.
  • Karabulut AB, Kafkaslı A, Burak F, Gozukara EM. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct. 2005;23(4):279–83. doi:10.1002/cbf.1152.
  • Kato H, Yoneyama Y, Araki T. Fetal plasma lipid peroxide levels in pregnancies complicated by preeclampsia. Gynecol Obstet Invest. 1997;43(3):158–61. doi:10.1159/000291845.
  • Howlader MZH, Parveen S, Tamanna S, Khan TA, Begum F. Oxidative stress and antioxidant status in neonates born to pre-eclamptic mother. J Trop Pediatr. 2009;55(6):363–7. doi:10.1093/tropej/fmp025.
  • Catarino C, Santos-Silva A, Belo L, Rocha-Pereira P, Rocha S, Patrício B, Quintanilha A, Rebelo I. Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood. J Pregnancy. 2012;2012:684384. doi:10.1155/2012/684384.
  • Gumus E, Atalay MA, Cetinkaya Demir B, et al. Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia. J Matern-Fetal Neonatal Med. 2016;29:3806–11.
  • Tsukahara H, Ohta N, Tokuriki S, Nishijima K, Kotsuji F, Kawakami H, Ohta N, Sekine K, Nagasaka H, Mayumi M, et al. Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood. Metabolism. 2008;57(2):215–20. doi:10.1016/j.metabol.2007.09.003.
  • Anderssohn M, Maass LM, Diemert A, Lüneburg N, Atzler D, Hecher K, Böger RH. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2012;161(2):152–6. doi:10.1016/j.ejogrb.2011.12.032.
  • Tamás P, Bódis J, Sulyok E, Kovács GL, Hantosi E, Molnár G, Martens-Lobenhoffer J, Bode-Böger SM. L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies. Scand J Clin Lab Invest. 2013;73(5):436–43. doi:10.3109/00365513.2013.803230.
  • Xiong Y, Zhou S-F, Zhou R, Yang D, Xu Z-F, Lou Y-T, Guo Q-S, Hu R, Peng T, Ma D, et al. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery. Hyperten Pregnancy. 2011;30(3):347–58. doi:10.3109/10641950903572274.
  • Bharati KP, Prashanth UR. Von Willebrand disease: an overview. Indian J Pharm Sci. 2011;73(1):7–16. doi:10.4103/0250-474X.89751.
  • Ogland B, Romundstad PR, Vefring H, Forman MR, Nilsen ST, Vatten LJ. Preeclampsia and adiponectin in cord blood. Horm Res Paediatr. 2010;74(2):92–7. doi:10.1159/000313376.
  • Kajantie E, Hytinantti T, Hovi P, Andersson S. Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. J Clin Endocrinol Metab. 2004;89(8):4031–6. doi:10.1210/jc.2004-0018.
  • Magalhães E. S d S, Méio MDBB, Peixoto-Filho FM, Gonzalez S, da Costa ACC, Moreira MEL. Pregnancy-induced hypertension, preterm birth, and cord blood adipokine levels. Eur J Pediatr. 2020;179(8):1239–46. doi:10.1007/s00431-020-03586-8.
  • Vitoratos N, Chrystodoulacos G, Kouskouni E, Salamalekis E, Creatsas G. Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2001;96(1):59–62. doi:10.1016/S0301-2115(00)00401-2.
  • Kharb S, Nanda S. Patterns of biomarkers in cord blood during pregnancy and preeclampsia. Curr Hypertens Rev. 2017;13(1):57–64.
  • Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci. 2009;16(10):921–37. doi:10.1177/1933719109336614.
  • Cho GJ, Yoo SW, Hong SC, Oh M-J, Kim T, Kim HJ, Lee KW, Kim SH. Correlations between umbilical and maternal serum resistin levels and neonatal birth weight. Acta Obstet Gynecol Scand. 2006;85(9):1051–6. doi:10.1080/00016340500470150.
  • Lausten-Thomsen U, Christiansen M, Hedley PL, et al. Adipokines in umbilical cord blood from children born large for gestational age. J Pediatr Endocrinol Metab JPEM. 2016;29:33–7.
  • Diamond FB, Cuthbertson D, Hanna S, et al. Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab JPEM. 2004;17:1069–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.